Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Receives CIA Venture Funding to Develop Microfluidics for DNA Detection

NEW YORK, Nov. 23 (GenomeWeb News) - Fluidigm has received funding from a CIA-funded venture group to develop new microfluidics technology for DNA detection, the company said yesterday.

 

In-Q-Tel, the not-for-profit venture group, will pay South San Francisco-based Fluidigm upfront and milestone fees and make an equity investment in the company. The funding will help Fluidigm to develop its integrated fluidic circuits technology, which can be used to collect and analyze DNA sequence information.

 

Fluidigm plans to develop two different IFC architectures, one that improves detection sensitivity, and another one that will enable users to detect specific sequences with high confidence using less sample.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.